Evogene Ltd. - Report Publication Announcement 2023

_________ false


	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	16/11/2023
	www.isa.gov.il			www.tase.co.il				Reference:	2023-02-125046	Time of broadcast: 19:17 19:17

Amended report for distorted report sent on date 15/11/2023 Whose reference number was: 2023-02-124494


The distortion:	Financial tables were disrupted
The distortion cause:	Technical amendment due to accessibility process
The main amendment:	The financial tables in the report were adjusted

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onEvogene Reports Third Quarter 2023 Financial Results

EVGNQ3_isa.pdf

Link to filing on foreign stock exchange (optional): _________



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 10/10/2023
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected] Company site: www.evogene.com

Previous names of reporting entity:

Name of the Signatory: Deutsch Nitsan Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7638517 Telephone: 08-9311900 Facsimile: 08-9466724 E-mail: [email protected] 1

AI assistant